| Drug (Blue = First line) |
‣ > ‣, |
|
|
|
|
|
| ‣, ‣, ‣, ‣ |
NA |
‣, ‣ |
NA |
NA |
‣ + ‣, ‣, Varenicline mono, NRT mono |
|
| Psychotherapy |
‣ |
MI |
MI |
Contingency Management |
MI |
MI, Set Quit Date |
| Intox S/S |
Ataxia, Amnesia, dis-inhibition, r/o DKA |
‣ , Incoordination, ‣ |
‣ + ‣ / AMS / impaired memory |
‣, ‣, ‣ , chills/nausea, UDS+ |
‣, ‣, Red Eye, Tachycardia, dry moth (2/4) |
NA |
| Intox tm |
Supportive Care |
Supportive care, IMV |
‣, IMW |
Supportive, +/- D2i |
Supportive, +/- D2i |
NA |
| Withdrawal Timeline |
6-12 hr to 5 dys |
2-7 dys. |
min - dys |
hrs - dys |
3 dy-1wk, insomnia 30 dys |
NA |
| Withdrawal S/S |
Tremor → Hallucination (‣)→ ‣ → ‣ |
ANS excitation, Rebound Anxiety, ‣, ‣ |
ANS excitation, Anxiety, ‣, ‣ |
‣, Fatigue, Depression |
Non-specific. Restless, ‣, Anxiety, Depression, ‣ |
NA |
| Withdrawal tm |
‣ / ‣, ‣, ‣ |
Same as EtOH. |
|
|
|
|
| Avoid by Prolonged taper (-5 mg or 10% per wk) |
‣, ‣, ‣ |
Supportive Care |
Supportive Care |
NA |
|
|